BRPI0414803A - derivados de ácido 4-(1-benzofuran-3-il-metilidenoaminoxi-propóxi)-benz óico e compostos relacionados como inibidores de pai-1 para o tratamento de dano do sistema fibrinolìtico e de trombose - Google Patents

derivados de ácido 4-(1-benzofuran-3-il-metilidenoaminoxi-propóxi)-benz óico e compostos relacionados como inibidores de pai-1 para o tratamento de dano do sistema fibrinolìtico e de trombose

Info

Publication number
BRPI0414803A
BRPI0414803A BRPI0414803-7A BRPI0414803A BRPI0414803A BR PI0414803 A BRPI0414803 A BR PI0414803A BR PI0414803 A BRPI0414803 A BR PI0414803A BR PI0414803 A BRPI0414803 A BR PI0414803A
Authority
BR
Brazil
Prior art keywords
aryl
heteroaryl
alkyl
pai
thrombosis
Prior art date
Application number
BRPI0414803-7A
Other languages
English (en)
Inventor
Lisa Marie Havran
John Anthony Butera
Hassan Mahmoud Elokdah
Douglas John Jenkins
Eric Gould Gundersen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0414803A publication Critical patent/BRPI0414803A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

"DERIVADOS DE áCIDO 4-(1-BENZOFURAN-3-IL-METILIDENOAMINOXI-PROPóXI)-BENZ óICO E COMPOSTOS RELACIONADOS COMO INIBIDORES DE PAI-1 PARA O TRATAMENTO DE DANO DO SISTEMA FIBRINOLìTICO E DE TROMBOSE". A presente invenção refere-se a oximas de benzofurila de fórmula (I) ou um sal farmaceuticamente aceitável ou forma de éster deste, em que R~ 1~ é uma ligação direta a A, C~ 1~-C~ 4~ alquileno, ou -O-C~ 1~-C~ 4~ alquileno; R~ 2~ e R~ 3~ são, independentemente, hidrogênio, halogênio, C~ 1~-C~ 4~ alquila, C~ 1~-C~ 3~ perfluoroalquila, -O-C~ 1~-C~ 3~ perfluoroalquila, C~ 1~-C~ 3~ alcóxi, -OH, -NH~ 2~, -NO~ 2~, arila, heteroarila, -O(CH~ 2~)~ p~-arila, -O(CH~ 2~)~ p~-heteroarila, -NH(CH~ 2~)~ p~-arila, -NH(CH~ 2~)~ p~heteroarila, -NH(CO)-arila, -NH(CO)-heteroarila, -O(CO)-arila, -O(CO)heteroarila, -NH(CO)-CH=CH-arila, ou -NH(CO)-CH=CH-heteroarila; p é um número inteiro de 0 a 6; R~ 4~ é hidrogênio, C~ 1~-C~ 8~ alquila, ou C~ 3~-C~ 6~ cicloalquila; A é -COOH ou uma mímica de ácido; X é C~ 1~-C~ 8~ alquileno, C~ 3~-C~ 6~ cicloalquileno, -(CH~ 2~)~ m~O-, ou -(CH~ 2~)~ m~NH-; m é um número inteiro de 1 a 6; e R~ 5~ é hidrogênio, C~ 1~-C~ 8~ alquila, C~ 3~-C~ 6~ cicloalquila, -CH~ 2~-C~ 3~-C~ 6~ cicloalquila, heteroarila, -CH~ 2~-heteroarila, arila, ou benzila; R~ 6~ e R~ 7~, são, independentemente, hidrogênio, halogênio, C~ 1~-C~ 6~ alquila, C~ 1~-C~ 6~ perfluoroalquila, -O-C~ 1~-C~ 6~ perfluoroalquila, C~ 1~-C~ 6~ alcóxi, -OH, -NH~ 2~, -NO~ 2~, -O(CH~ 2~)~ n~-arila, -O(CH~ 2~)~ n~-heteroarila, arila, ou heteroarila; e n é um número inteiro de 0 a 6, onde os grupos de alquila, cicloalquila, arila e heteroarila são cada opcionalmente substituído por um ou mais substituintes. Os presentes compostos são inibidores de PAI-1 para o tratamento por exemplo de enfraquecimento do sistema fibrinolítico, trombose ou doenças cardiovasculares.
BRPI0414803-7A 2003-09-25 2004-09-24 derivados de ácido 4-(1-benzofuran-3-il-metilidenoaminoxi-propóxi)-benz óico e compostos relacionados como inibidores de pai-1 para o tratamento de dano do sistema fibrinolìtico e de trombose BRPI0414803A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50580103P 2003-09-25 2003-09-25
US10/947,930 US20050215626A1 (en) 2003-09-25 2004-09-23 Substituted benzofuran oximes
PCT/US2004/031361 WO2005030199A1 (en) 2003-09-25 2004-09-24 4-(1-benzofuran-3-yl-methylideneaminoxy.propoxy))-benzoic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombosis

Publications (1)

Publication Number Publication Date
BRPI0414803A true BRPI0414803A (pt) 2006-11-14

Family

ID=34396267

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414803-7A BRPI0414803A (pt) 2003-09-25 2004-09-24 derivados de ácido 4-(1-benzofuran-3-il-metilidenoaminoxi-propóxi)-benz óico e compostos relacionados como inibidores de pai-1 para o tratamento de dano do sistema fibrinolìtico e de trombose

Country Status (8)

Country Link
US (1) US20050215626A1 (pt)
EP (1) EP1667676A1 (pt)
JP (1) JP2007506758A (pt)
AU (1) AU2004275807A1 (pt)
BR (1) BRPI0414803A (pt)
CA (1) CA2538574A1 (pt)
MX (1) MXPA06003250A (pt)
WO (1) WO2005030199A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074817B2 (en) * 2001-06-20 2006-07-11 Wyeth Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
TWI224101B (en) * 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
EP1569900B1 (en) * 2002-12-10 2006-06-28 Wyeth Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
CA2509170A1 (en) * 2002-12-10 2004-06-24 Wyeth Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
UA80453C2 (en) * 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
DE60324183D1 (en) * 2002-12-10 2008-11-27 Wyeth Corp Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7534894B2 (en) * 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7265148B2 (en) * 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7446201B2 (en) * 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7163954B2 (en) * 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7332521B2 (en) * 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7582773B2 (en) * 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7141592B2 (en) * 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7268159B2 (en) * 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7442805B2 (en) * 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7411083B2 (en) * 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
CN101044127A (zh) 2004-08-23 2007-09-26 惠氏公司 用作纤溶酶原激活剂抑制剂－1的噻唑基－萘基酸
AU2005277137A1 (en) * 2004-08-23 2006-03-02 Wyeth Pyrrolo-naphthyl acids as PAI-1 inhibitors
WO2006023865A1 (en) * 2004-08-23 2006-03-02 Wyeth Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
BRPI0614340A2 (pt) * 2005-08-17 2011-04-12 Wyeth Corp indóis substituìdos e métodos de seu uso
AR059629A1 (es) * 2006-02-27 2008-04-16 Wyeth Corp Inhibidores del inhibidor del activador de plasminogeno (pai- 1) para el tratamiento de trastornos musculares
US8633245B2 (en) * 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3147276A1 (de) * 1981-11-28 1983-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole
DE3413363A1 (de) * 1984-04-09 1985-10-17 Merz + Co GmbH & Co, 6000 Frankfurt Benzofuran-2-yl-ethyl-imidazolderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3531658A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
DE58908972D1 (de) * 1988-12-29 1995-03-16 Ciba Geigy Ag Aldimino- oder ketimino-oxy-ortho-tolylacrylsäure-methylester, ihre herstellung und diese enthaltende fungizide.
NZ242290A (en) * 1991-04-15 1994-12-22 Zeneca Ltd Pyridyl and pyrimidinyl substituted oxime-o-benzyl ether derivatives; preparatory processes, fungicidal compositions and an intermediate
DE4213149A1 (de) * 1992-04-22 1993-10-28 Hoechst Ag Akarizide, insektizide und nematizide substituierte (Hetero)-Aryl-Alkyl-ketonoxim-O-ether, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
EP0608862A1 (en) * 1993-01-27 1994-08-03 Lucky Ltd. Novel 6-chloro-2-(4,6-dimethoxypyrimidin-2-yl) oxybenzoic acid ester derivatives, processes for their production an a method for their application as herbicides
US5599663A (en) * 1993-08-27 1997-02-04 Brighan & Women's Hospital Angiotensin IV and analogs as regulators of fibrinolysis
JPH09508373A (ja) * 1994-01-27 1997-08-26 チバーガイギー アクチェンゲゼルシャフト パラジウム触媒による交差カップリング反応を経由するアリール酢酸エステル誘導体の製造方法
WO1996036615A1 (en) * 1995-05-16 1996-11-21 E.I. Du Pont De Nemours And Company Fungicidal cyclic amides
ATE239004T1 (de) * 1996-05-20 2003-05-15 Darwin Discovery Ltd Benzofuran carboxamide und ihre therapeutische anwendung
EP1125931A1 (en) * 2000-02-17 2001-08-22 Hunan Research Institute of Chemical Industry Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof
US6605615B2 (en) * 2000-03-01 2003-08-12 Tularik Inc. Hydrazones and analogs as cholesterol lowering agents

Also Published As

Publication number Publication date
US20050215626A1 (en) 2005-09-29
CA2538574A1 (en) 2005-04-07
JP2007506758A (ja) 2007-03-22
MXPA06003250A (es) 2006-06-08
WO2005030199A1 (en) 2005-04-07
EP1667676A1 (en) 2006-06-14
AU2004275807A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
BRPI0414803A (pt) derivados de ácido 4-(1-benzofuran-3-il-metilidenoaminoxi-propóxi)-benz óico e compostos relacionados como inibidores de pai-1 para o tratamento de dano do sistema fibrinolìtico e de trombose
BRPI0414462A (pt) derivados de ácido 4-(fenil-etilidenoaminóxi-propóxi)-fenil-acético e compostos relacionados como inibidores de pai-1 para o tratamento de dano do sistema fibrinolìtico e de trombose
AR057023A1 (es) Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
NO2015020I2 (no) Ceritinib eller et farmasøytisk akseptabelt salt derav
BRPI0414738A (pt) derivados de ácido acético substituìdos
CO5251463A1 (es) Compuestos heterociclicos y composicion farmaceutica que coniene dichos compuestos
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
EA200601235A1 (ru) Производные тиазола
RU2013103792A (ru) Новое производное никотинамида или его соль
EA200600509A1 (ru) Соединения пиримидотиофена
WO2004072047A8 (en) Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors
ATE540021T1 (de) Hydroxansäurederivate als inhibitoren der enzymatischen hdac-aktivität
CA3063111A1 (en) Histone deacetylases (hdacs) inhibitors
TW200745058A (en) MMP-13 selective inhibitors
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
WO2011137089A1 (en) Activators of human pyruvate kinase
BRPI0509588A (pt) derivados e tetraidronaftiridina e um processo para preparação dos mesmos
EP2209765A2 (en) Histone deacetylase inhibitors
MA30311B1 (fr) Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
MX2008013728A (es) Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo.
Başaran et al. Synthesis of novel chiral sulfonamide‐bearing 1, 2, 4‐triazole‐3‐thione analogs derived from D‐and L‐phenylalanine esters as potential anti‐influenza agents
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
PT1590321E (pt) Derivados de arilalquilcarbamatos, sua preparaã†o e sua aplicaã†o em terapia
NZ612336A (en) Novel substituted isoquinoline derivative
WO2009028387A1 (ja) プロテアーゼ阻害剤耐性を有する癌の治療薬

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.